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Table 1.  Animal characteristics of included studies 
Species Animals  Studies Weight range Awake, % References 
Rat 1149 31 120–460 g 0 (20-22, 33, 38-40, 44, 46, 48, 49, 52-
55, 62, 66, 70-75, 79-81, 86-90) 
Hamster 518 26 40–75 g 100 (23-32, 45, 47, 50, 58, 60, 61, 63, 68, 
69, 76-78, 82-85) 
Rabbit 94 3 0.8–3.5 kg  0 (51, 57, 59) 
Pig 74 4 7–45 kg 0 (41-43, 56) 
Mouse 68 2 25–30 g 0 (64, 65) 
Dog 56 5 22–35 kg  0 (34-37, 67) 
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Table 2. Summary of haemorrhage protocol targets and timings 
Haemorrhage 
protocol N 
Target % 
of blood 
volume 
lost 
Target MAP, 
mmHg 
Target 
% of 
MAP 
Target 
mL/kg 
bled 
Period of 
shock, 
minutes  
References 
Volume controlled haemorrhage 
% of total blood volume 
lost  
27 50 (50–50)  N/A N/A N/A 60 (60–60) (24-32, 51, 56, 
58, 61-63, 71-
74, 76-78, 82-
85, 89) 
 
Bled a specific volume 
of blood per kg 
6 N/A N/A N/A 30 (30–30) 40 (30–57.5)  (41, 42, 46, 48, 
86, 87) 
Pressure controlled haemorrhage 
Bled to a target MAP 26 N/A 40 (37.5–40)  N/A N/A 60 (45–60) (20-22, 33, 38-
40, 44, 45, 47, 
49, 52-55, 59, 
64-67, 75, 79-
81, 88, 90) 
 
Bled to both % of total 
blood volume and 
target MAP  
11 50 (40–50) 40 (37.5–48.8)  N/A N/A 45 (36–60)  (23, 34-37, 43, 
50, 57, 60, 68, 
69) 
 
Bled to a % of MAP 1 N/A N/A 50 N/A 30* (70) 
All values are expressed as median, with interquartile range in brackets unless otherwise specified 
*This is a single value rather than a median 
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Table 3. Anatomical location and techniques for microcirculatory parameter 
acquisition 
 
 
  References       
Anatomical 
location 
Studies Intravital 
microscopy 
Laser 
speckle 
contrast 
imaging 
Sidestream 
darkfield 
microscopy 
Laser 
Doppler 
flowmetry 
probe 
Electron 
microscopy 
Orthogonal 
polarization 
spectral 
imaging 
Dorsal skin fold 26 (23-32, 45, 47, 
50, 58, 60, 61, 
63, 68, 69, 76-
78, 82-85) 
     
Bowel / 
mesentery 
15 (33, 39, 46, 48, 
49, 62, 70, 89) 
(86, 87) (59, 67) (44) (52) (75) 
Liver 9 (20, 21, 38, 53, 
55, 66, 79) 
(86, 87)  (38)   
Cremaster 5 (64, 65, 71, 73, 
74) 
     
Skeletal muscle 6 (22, 39, 40, 57) (86, 87)     
Conjunctiva 4 (34-37)      
Sublingual 5   (41, 42, 56) (43, 56)   
Kidney 5 (39) (86, 87)  (44, 54)   
Pancreas 2 (80, 81)      
Brain 2    (44, 54)   
Internal spermatic 
fascia 
1 (88)      
Buccal mucosa 1   (67)    
Ear chamber 1 (51)      
Heart 1    (44)   
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Table 4. Summary of study findings regarding haemoglobin-carrying fluids 
Study Animal Method Test fluid(s) Control fluid(s) or sham Endpoint(s) Main finding 
A.  Haemoglobin based oxygen carriers 
Bi  
2004 
Rat IVM PEG-Hb (3 different 
volumes)  
Whole blood (2 
different volumes) 
and dextran and 
HC  
Velocity, flow, 
diameter   
HBOC superior to non Hb carrying 
fluid, and equivalent to whole 
blood 
Botzlar  
1996 
Hamster  IVM U-PBHb 11g/dL and 13g/dL Dextran and LR Diameter, FCD HBOC superior to non Hb carrying 
fluid 
Cabrales 
2009 
Hamster IVM PBH 13g/dL and PBH 4g/dL Albumin Velocity, flow, 
diameter, FCD 
HBOC superior to non Hb-carrying 
fluid 
Cheung  
2001 
Canine IVM Bovine Hb glutamer-200  Whole blood Velocity, 
diameter 
HBOC equivalent to whole blood 
Cheung  
2004 
Canine IVM Oxyglob Whole blood and 
6% hetastarch 
Velocity, 
diameter 
HBOC equivalent to non Hb-
carrying fluid and whole blood 
Cheung  
2006 
Canine IVM Oxyglobin  Whole blood and 
NS and 6% 
hetastarch  
Velocity, 
diameter 
HBOC equivalent to non Hb-
carrying fluid and whole blood 
Cheung  
2007 
Canine IVM Oxyglobin  Whole blood and 
NS and 6% 
hetastarch  
Velocity, 
diameter 
HBOC equivalent to non Hb-
carrying fluid and whole blood 
Gulati  
1998 
Rat  LDF DCLHb (3 different 
concentrations) 
LR Velocity, 
perfusion 
HBOC superior to non Hb carrying 
fluid 
Hermann 
2007 
Hamster IVM Recombinant Hb wild type 
and rcombinant Hb nitric-
oxide scavenging 
6% dextran Velocity, 
diameter, FCD 
Nitric-oxide scavenging HBOC 
superior to HBOC or non Hb 
carrying fluid 
Hungerer 
2006 
Hamster IVM DCLHb    Whole blood and 
dextran 
Velocity, FCD HBOC equivalent to whole blood 
and non Hb carrying fluid 
Kerger  
1997 
Hamster  IVM Cell-free o-raffinose cross-
linked oligomerized Hb 
Whole blood and 
LR and dextran 
Velocity, flow, 
diameter, FCD 
HBOC superior to non Hb-carrying 
fluid and equivalent to whole blood 
Kubulus  
2009 
Rat IVM Hb glutamer-200 Whole blood  Velocity, flow, 
diameter, PVD 
HBOC equivalent to whole blood 
Kumar  
1997 
Rat  LDF DCLHb LR Velocity, 
perfusion 
HBOC superior to non Hb carrying 
fluid 
Nolte  
1997 
Hamster IVM DCLHb  Whole blood and 
dextran 
Velocity, 
diameter, FCD 
HBOC superior to whole blood and 
non Hb carrying fluid 
Ortiz  
2014 
Hamster IVM Bovine Hb glutamer-250 at 
4, 8, and 12 g/dL 
Whole blood Velocity, flow, 
FCD 
HBOC superior to whole blood; 
lower Hb preparations superior to 
higher 
Palmer  
2011 
Hamster IVM Polymerised human Hb and 
polymerised bovine Hb 
HSA Velocity, flow, 
FCD 
HBOC superior to non Hb carrying 
fluid; bovine preparation of Hb 
superior to human 
Sakai  
2002 
Hamster  IVM Vesicle-encapsulated Hb 
3g/dL and 7g/dL 
Whole blood and 
HSA  
Velocity, flow, 
diameter, FCD 
HBOC superior to non Hb carrying 
fluid but inferior to whole blood 
Vazquez  
2011 
Hamster IVM Oxyglobin  HES    Diameter, FCD HBOC superior to non Hb carrying 
fluid 
von 
Dobschuetz 
1999 
Rat IVM DCLHb  Whole blood and 
HES  
FCD HBOC superior to non Hb carrying 
fluids and equivalent to whole 
blood 
Wettstein 
2003 
Hamster IVM PEG-Hb  Whole blood and 
HES 
Velocity, flow, 
diameter, FCD 
HBOC superior to whole blood and 
non Hb carrying fluid 
Wettstein 
2004(a) 
Hamster  IVM PEG-Alb PEG-Hb (from 
earlier experiment) 
Velocity, flow 
rate, diameter, 
FCD 
HBOC equivalent to non Hb 
carrying fluid 
B.  Red cells and whole blood 
Casali  
2002 
Rat  IVM Whole blood LR Velocity Whole blood superior to crystalloid 
Kao  
2010 
Rat IVM Whole blood and whole 
blood/EPO 
NS and NS/EPO Flow, perfusion Whole blood superior to crystalloid 
Ni  
2013 
Rabbit SDF Whole blood and LR and 
whole blood/LR 
Sham TVD, PVD, PPV, 
MFI 
Blood and crystalloid combined 
superior to either fluid on its own 
Paxian  
2003 
Rat  IVM PRBC and perflubron 
emulsion/HES and 
PRBC/perflubron emulsion 
LR and HES and 
whole blood 
Diameter, 
velocity, flow 
O2 emulsion superior to whole 
blood, red cells, or non-oxygen 
carrying fluid 
Sakai  
1999 
Hamster  IVM Whole blood HSA Velocity, flow, 
diameter, FCD 
Whole blood is superior to colloid 
Villela  
2009 
Hamster IVM High O2-affinity PRBC 
(50mmHg) 
Low O2-affinity 
PRBC (10mmHg) 
Velocity, flow, 
diameter, FCD 
Lower O2 affinity of red cells 
superior to higher 
Techniques: IVM: intravital microscopy; LDF: laser doppler flowmetry; SDF: sidestream darkfield microscopy 
Endpoints: PVD: perfused vessel density; TVD: total vessel density; PPV: proportion of perfused vessels; MFI: microvascular flow index; HI: heterogeneity 
index; FCD: functional capillary density;  
Fluids: HBOC: haemoglobin based oxygen carrier; PRBC: packed red blood cells; LR: Ringer's lactate; NS: normal saline; HTS: hypertonic saline; HSA: 
human serum albumin; HC: haemorrhage control; HES: hydroxyl-ethyl starch; PBH: polymerized bovine haemoglobin; PEG-Alb: polyethylene glycol-
conjugated albumin; PEG-Hb: polyethylene glycol-conjugated haemoglobin; UPBHb: ultrapurified polymerised bovine haemoglobin solution; DCLHb: 
diaspirin cross-linked haemoglobin; Hb: haemoglobin; EPO: erythropoietin 
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Table 5. Summary of study findings regarding osmotic/oncotic pressure 
Study Animal Method Test fluid(s) 
Control 
fluid(s) or 
sham 
Endpoint(s) Main finding 
Bauer  
1993 
Rat IVM 7.2% HTS/Dextran 
and 7.2%HTS/10% 
HES 
LR and 
Sham 
Velocity, flow, 
diameter   
Hypertonic and isotonic 
fluids are equivalent 
Cabrales  
2005(b) 
Hamster IVM 5% PEG-Alb 10% HES 
and HC 
Velocity, flow, 
diameter, FCD 
Length of time of oncotic 
pressure is important 
Cabrales  
2008(b) 
Hamster IVM 4% PEG-Alb 5% HSA 
and 10% 
HSA 
Velocity, flow, shear 
stress, diameter, 
FCD 
Increased plasma expansion 
superior with conjugated 
molecule 
Cryer  
2005 
Rat IVM 7.2% HTS/6% 
dextran and 
NS/dextran 
NS Velocity, flow, 
diameter   
Effects of 
hypertonic/hyperosmotic 
fluid last longer than isotonic 
Gierer  
2004 
Rat IVM 10% HES and 7.2% 
HTS/6% HES 
NS FCD Hypertonic/hyperosmotic 
fluid is superior  
Kao  
2011 
Rat IVM 7.5% HTS and 7.5% 
HTS/EPO 
NS and 
NS/EPO 
and LR and 
LR/EPO 
PVD    Hypertonic crystalloid 
inferior to isotonic 
Komori  
2005 
Rabbit IVM HES LR Velocity, flow, 
diameter   
Hypertonic/hyperosmotic 
fluid is superior  
Maier  
2009 
Porcine LDF and 
SDF 
Gelatine and 7.2% 
HTS/6% HES 
6% HES Flow, capillary 
density, MFI 
Hypertonic and isotonic 
fluids equivalent  
Mazzoni  
1990 
Rabbit IVM HTS/dextran  LR Diameter Hypertonic/hyperosmotic 
fluid is superior  
Paes-da-
Silva  
2003 
Rat IVM and 
LDF 
7.5% HTS and 5% 
BSA and NS/HES 
and HTS/HES 
Whole 
blood and 
NS 
Diameter, flow Hypertonic/hyperosmotic 
fluid is superior  
Pascual  
2001 
Mouse IVM Pentastarch and LR Sham Diameter, velocity, 
shear rate 
Hypertonic and isotonic 
fluids equivalent  
Pascual  
2002 
Mouse IVM  7.5% HTS and LR Sham Velocity, shear rate, 
shear stress 
Hypertonic and isotonic 
fluids equivalent  
Scalia  
1990 
Rat IVM HTS/dextran and 
dextran 
Whole 
blood 
Diameter Hypertonic fluid superior to 
whole blood 
Vajda  
2004 
Rat OPS HTS/HES NS Velocity, flow, FCD Hypertonic/hyperosmotic 
fluid is superior  
Vollmar  
1994 
Rat IVM 10% HES and 7.2% 
HTS/10% HES 
LR and 
Sham 
Velocity, perfusion Hypertonic/hyperosmotic 
fluid is superior  
Vollmar  
1996 
Rat IVM and 
LDF 
10% HES and 7.2% 
HTS/10% HES 
LR Velocity, diameter, 
flow, FCD 
Hypertonic/hyperosmotic 
fluid is superior  
Wu  
2015(b) 
Rat LSCI NS and HTS and 
gelatine and HES 
Sham and 
HC 
Flow Hypertonic/hyperosmotic 
fluid is superior  
Zakaria  
2006 
Rat IVM Whole blood/NS and 
whole blood/HTS 
and HTS/NS 
Sham Diameter, flow Hypertonic/hyperosmotic 
fluid is superior when given 
with whole blood 
Zhao  
2009 
Rat IVM NS and HTS and 
HTS/dextran     
Sham and 
HC 
Shear rate Hypertonic/hyperosmotic 
fluid improves RBC 
deformability 
Techniques: IVM: intravital microscopy; LDF: laser doppler flowmetry; LSCI: laser speckle contrast imaging; SDF: sidestream 
darkfield microscopy; OPS: orthogonal polarization spectral imaging 
Endpoints: MFI: microvascular flow index; FCD: functional capillary density; PVD: perfused vessel density 
Fluids: LR: Ringer's lactate; NS: normal saline; HTS: hypertonic saline; HSA: human serum albumin; HC: haemorrhage-only control; 
HES: hydroxyl-ethyl starch: BSA: bovine serum albumin; EPO: erythropoietin 
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Table 6. Summary of study findings regarding viscosity 
Study Animal Method Test fluid(s) Control fluid(s) or sham Endpoint(s) Main finding 
Cabrales  
2004 
Hamster IVM 0.7% and 0.8% 
LVM alginate  
5% HES and HC Velocity, flow, shear 
stress, diameter, 
FCD 
Higher viscosity superior 
to lower 
Cabrales  
2005(a) 
Hamster IVM 10% HES/0.3% 
alginate and 10% 
HES/0.6% 
alginate 
10% HES Velocity, flow, 
diameter, FCD 
Higher viscosity superior 
to lower  
Cabrales  
2007(a) 
Hamster IVM OxyRBC and 
MetRBC 
Fresh plasma Velocity, flow, shear 
stress, diameter, 
FCD 
Higher viscosity superior 
to lower, independent of 
O2 carrying capacity 
Cabrales  
2007(b) 
Hamster IVM High-MW HES Low-MW HES 
and Sham 
Velocity, flow, FCD Higher viscosity superior 
to lower   
Cabrales  
2007(c) 
Hamster IVM OxyRBC and 
MetRBC 
10% HES Velocity, flow, shear 
stress, diameter, 
FCD 
Higher viscosity superior 
to lower, independent of 
O2 carrying capacity 
Cabrales  
2008(a) 
Hamster IVM 6% hetastarch 
/0.4% alginate 
6% hetastarch 
and HC 
Velocity, flow, shear 
stress, FCD 
Higher viscosity superior 
to lower  
Guerci  
2014 
Porcine LDF HES/7% HTS LR Perfusion No difference between 
viscosities 
Messmer  
2012  
Hamster IVM High MW 
Polymerised HSA 
(3 different 
concentrations) 
HSA Velocity, flow, shear 
stress, diameter, 
FCD 
Higher viscosity superior 
to lower  
Peruski  
2014 
Canine SDF HBOC-alginate 
(hyperviscous) 
Standard HBOC PVD, TVD, MFI, PPV Higher viscosity 
equivalent to lower  
Villela  
2011 
Hamster IVM LR-alginate  LR Velocity, flow, 
diameter, FCD 
Higher viscosity superior 
to lower  
Wettstein  
2004(b) 
Hamster IVM PEG-BSA/PRBC 
at 4 and 8 g/dL 
PEG-BSA Velocity, flow, 
diameter, FCD 
Higher viscosity superior 
to lower and more 
important than oxygen 
carrying capacity 
Wettstein  
2006 
Hamster IVM 5% HES and 10% 
HES and 20% 
HES 
HC     Velocity, flow, FCD Higher viscosity superior 
to lower  
 Techniques: IVM: intravital microscopy; LDF: laser doppler flowmetry; SDF: sidestream darkfield microscopy 
Endpoints: PVD: perfused vessel density; TVD: total vessel density; PPV: proportion of perfused vessels; MFI: microvascular flow 
index; HI: heterogeneity index; FCD: functional capillary density  
Fluids: HBOC: haemoglobin based oxygen carrier; PRBC: packed red blood cells; LR: Ringer's lactate; HSA: human serum albumin; 
HTS: hypertonic saline; MW: molecular weight; HC: haemorrhage-only control; HES: hydroxyl-ethyl starch; OxyRBC: oxygen-carrying 
red blood cells; MetRBC: methemoglobin red blood cells; PEG-BSA: pegylated bovine albumin; LVM: low viscosity high-mannuronic 
acid 
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Table 7. Summary of study findings regarding attenuation of inflammation  
Study Animal Method Test fluid(s) 
Control 
fluid(s) or 
sham 
Endpoint(s) Main finding 
Bauer  
1993 
Rat IVM 7.2% HTS-
Dextran and 
7.2% HTS/10% 
HES 
LR and 
Sham 
Velocity, 
flow, 
diameter 
Modified fluid can reduce leucocyte 
adhesion and restore microcirculatory 
flow 
Bauer  
1995 
Rat IVM HES-
desferoxamine 
conjugate 
HES and 
Sham 
Velocity, flow Modified fluid to scavenge free radicals 
can reduce leucocyte adhesion and 
restore microcirculatory flow 
Corso  
1999 
Rat IVM and 
LDF 
6% dextran and 
7.2% HTS/10% 
dextran 
LR Velocity, 
flow, shear 
stress 
Hypertonic fluid no difference in flow 
but attenuates leukocyte adhesion  
Horstick  
2002 
Rat IVM 20% albumin NS Velocity, 
shear rate 
Albumin has anti-inflammatory 
properties  
Maier  
2004 
Rat IVM Gelatine and 
5%HSA and 
SPS 
Sham Diameter, 
velocity, flow 
Serum protein solution can reduce 
inflammation 
Pascual  
2001 
Mouse  IVM Pentastarch and 
LR 
Sham Diameter, 
velocity, 
shear rate 
Hypertonic fluid attenuates leukocyte 
adhesion  
Pascual  
2002 
Mouse IVM  7.5% HTS and 
LR 
Sham Velocity, 
shear rate, 
shear stress 
Hypertonic fluid attenuates leukocyte 
adhesion  
Vollmar  
1994 
Rat IVM 10% HES and 
7.2% HTS/10% 
HES 
LR and 
Sham 
velocity, 
perfusion 
Hypertonic fluid attenuates leukocyte 
adhesion  
Yada-
Langui 
2004 
Rat IVM HTS LR Velocity, 
shear rate 
Hypertonic fluid attenuates leukocyte 
adhesion  
Techniques: IVM: intravital microscopy; LDF: laser doppler flowmetry;  
Fluids: LR: Ringer's lactate; NS: normal saline; HTS: hypertonic saline; HES: hydroxyl-ethyl starch; SPS: serum protein solution; 
HSA: human serum albumin 
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Table 8. Summary of study findings regarding restorative properties of the fluid 
 
Study Animal Method Test fluid(s) Control fluid(s) or sham Endpoint(s) Main finding 
Kozar  
2011 
Rat Electron 
microscopy 
Fresh plasma LR and Sham 
and HC 
Glycocalyx 
thickness 
Plasma can restore the 
endothelial glycocalyx  
Torres  
2013 
Rat IVM FFP LR and HES 
and HC and 
sham 
Velocity, diameter Plasma can restore the 
endothelial glycocalyx  
Torres  
2014 
Rat IVM  1:1 PRBC/LR 
and 1:1 washed 
PRBC/LR and 
whole blood 
LR and Sham Glycocalyx 
thickness, flow 
Constituents of plasma can 
restore the endothelial 
glycocalyx  
Torres  
2015(a) 
Rat IVM FFP NS and 3% 
HTS and Sham 
Glycocalyx 
thickness 
Plasma can restore the 
endothelial glycocalyx  
Torres  
2015(b) 
Rat IVM FFP NS Glycocalyx 
thickness, flow 
Plasma can restore the 
endothelial glycocalyx and 
flow 
Techniques: IVM: intravital microscopy 
Fluids: PRBC: packed red blood cells; LR: Ringer's lactate; NS: normal saline; HTS: hypertonic saline; HC: haemorrhage-only 
control; HES: hydroxyl-ethyl starch; FFP: fresh frozen plasma 
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Supplementary Table 1. Summary of information recorded during extraction of 
data from eligible studies 
 
Category Extracted data 
Study 
characteristics 
Author, year, type of publication, country of origin, 
design 
Animal 
characteristics 
Species, sex, number, weight, housing, awake or 
anaesthetised 
Haemorrhage 
protocol 
Percentage of volume of blood lost, mean arterial 
pressures, length of time of shock 
Microcirculation 
monitoring 
Anatomical location, technique used, endpoints 
recorded 
Intervention and 
control 
Allocation of intervention, hypothesis, fluids delivered, 
control arm, haemorrhage only or sham 
SYRCLE 
assessment 
Sequence generation, baseline characteristics, 
allocation concealment, housing, blinding, random 
outcome assessment, incomplete data, selective 
outcome reporting, other sources of bias 
Translatability Choice of sample size, flow of animals, appropriate 
control, dose-response relationship, matching to 
human manifestation, characteristic pathway, 
matching age, replication in different models, 
independent replication, different species 
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Supplementary Table 2. Resuscitative fluid comparisons in included studies 
 
Studies Sham (no 
haemorrhage) 
Haemorrhage 
only 
Blood 
product(s) 
Oxygen 
carrier(s) 
Crystalloid(s) Colloid(s) 
Torres 2013 ✔ ✔ ✔  ✔ ✔ 
Kozar 2011 ✔ ✔ ✔  ✔  
Zhao 2009, Wu 2015(b) ✔ ✔   ✔ ✔ 
Wu 2015(a) ✔ ✔   ✔  
Paxian 2003 ✔  ✔ ✔ ✔ ✔ 
Von Dobschuetz 1999 ✔  ✔ ✔  ✔ 
Kubulus 2009 ✔  ✔ ✔   
Paes-da-Silva 2003 ✔  ✔  ✔ ✔ 
Ni 2013, Torres 2014 ✔  ✔  ✔  
Torres 2015(a), Zakaria 
2006 
✔  ✔  ✔  
Bauer 1993, Pascual 
2001, Vajda 2004, 
Vollmar 1994 
✔    ✔ ✔ 
Bauer 1995, Cabrales 
2007(b), Maier 2004 
✔     ✔ 
Gulati 1998 ✔   ✔ ✔  
Pascual 2002, Yada-
Langui 2004 
✔    ✔  
Bi 2004  ✔ ✔ ✔  ✔ 
Cabrales 2004, Cabrales 
2005(b), Wettstein 2006 
 ✔    ✔ 
Cheung 2001, Ortiz 
2014, Wettstein 2004(b) 
  ✔ ✔   
Cheung 2006, Cheung 
2007, Kerger 1997 
  ✔ ✔ ✔ ✔ 
Cheung 2004, Hungerer 
2006, Nolte 1997, Sakai 
2002, Wettstein 2003 
  ✔ ✔  ✔ 
Casali 2002, Kao 2010, 
Torres 2015(b) 
  ✔  ✔  
Cabrales 2007(c), Sakai 
1999, Scalia 1990 
  ✔   ✔ 
Cabrales 2007(a), Villela 
2009 
  ✔    
Peruski 2014    ✔   
Kumar 1997    ✔ ✔  
Botzlar 1996    ✔ ✔ ✔ 
Cabrales 2009, Hermann 
2007, Palmer 2011, 
Vazquez 2011, Wettstein 
2004(a) 
   ✔  ✔ 
Kao 2011, Villela 2011     ✔  
Corso 1999, Cryer 2005, 
Gierer 2004, Gonzalez 
2012, Gonzales 2016, 
Guerci 2014, Horstick 
2002, Komori 2005, 
Mazzoni 1990, Vollmar 
1996 
    ✔ ✔ 
Cabrales 2005(a), 
Cabrales 2008(a), 
Cabrales 2008(b), Maier 
2009, Messmer 2012 
     ✔ 
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Supplementary Table 3. Assessment of bias based on the SYRCLE’s risk of bias 
tool for animal studies 
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Bauer 1993   *        *       2 
Bauer 1995 * *        *       3 
Bi 2004 * *           *     3 
Botzlar 1996   *                 1 
Cabrales 2004 * *                 2 
Cabrales 2005 (a) * *                 2 
Cabrales 2005 (b) * *                 2 
Cabrales 2007 (a) * *           *     3 
Cabrales  2007 (b) * *           *     3 
Cabrales  2007 (c) * *           *     3 
Cabrales 2008 (a) * *           *     3 
Cabrales 2008 (b) * *           *     3 
Cabrales  2009 * *           *     3 
Casali 2002                     0 
Cheung 2001 * *           *     3 
Cheung 2004 * *                 2 
Cheung 2006 * *                 2 
Cheung 2007 * *           *     3 
Corso 1999   *                 1 
Cryer  2005   *                 1 
Gierer 2004   *                 1 
Gonzalez 2012 *                   1 
Gonzalez 2016 * *        *       3 
Guerci 2014 * *           *     3 
Gulati 1998   *                 1 
Hermann 2007 * *                 2 
Horstick 2002 * *                 2 
Hungerer  2006 * *                 2 
Kao  2010 * *           *     3 
Kao 2011 *                   1 
Kerger  1997   *           *     2 
Komori 2005   *                 1 
Kozar 2011   *                 1 
Kubulus 2009 * *          *       2 
Kumar 1997   *                 1 
Maier  2004 *          *       2 
Maier  2009 * *        *       3 
Mazzoni 1990 * *           *     3 
Messmer  2012 * *           *     3 
Ni  2013 *                   1 
Nolte 1997 * *                 2 
Ortiz 2014 * *           *     3 
Paes-da-Silva 2003 * *                 2 
Palmer 2011 * *           *     3 
Pascual 2001 * *        *       3 
Pascual 2002 * *   *    *       4 
Paxian 2003   *                 1 
Peruski 2014 * *        *       3 
Sakai 1999   *   *       *     3 
Sakai 2002   *   *             2 
Scalia 1990   *                 1 
Torres 2013 * *                 2 
Torres 2014 * *           *     3 
Torres 2015 (a)   *                 1 
Torres 2015 (b)   *                 1 
Vajda  2004 * *                 2 
Vazquez  2011 * *           *     3 
Villela 2009 * *           *     3 
Villela 2011 * *           *     3 
Vollmar 1994 * *        *       3 
Vollmar 1996 * *                 2 
von Dobschuetz  1999 * *                 2 
Wettstein 2003 * *           *     3 
Wettstein  2004 (a)   *                 1 
Wettstein 2004 (b) * *                 2 
Wettstein 2006   *           *     2 
Wu 2015 (a) * *                 2 
Wu 2015 (b) * *                 2 
Yada-Langui 2004 *                   1 
Zakaria  2006 * *                 2 
Zhao  2009 * *                 2 
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Supplementary Table 4.  Assessment of translatability according to most frequent 
recommendation for preclinical researc 
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Bauer 1993    *    *   *        3 
Bauer 1995  * *  *  *   *        5 
Bi 2004  *   *  * *   *        5 
Botzlar 1996       *  *   *         3 
Cabrales 2004  *    *  *   *         4 
Cabrales 2005 (a)  *      *   *         3 
Cabrales 2005 (b)  *    *  *   *         4 
Cabrales 2007 (a)  *   *   *   *        4 
Cabrales  2007 (b)  *   * *  *   *        5 
Cabrales  2007 (c)  *   *   *   *        4 
Cabrales 2008 (a)  *   * *  *   *        5 
Cabrales 2008 (b)  *   *   *   *        4 
Cabrales  2009  *   *   *   *        4 
Casali 2002             *        1 
Cheung 2001  *   * *  *   *        5 
Cheung 2004  *    *  *   *        4 
Cheung 2006  *   *   *   *        4 
Cheung 2007  *   *   *   *        4 
Corso 1999      * *  *   *        4 
Cryer  2005         *   *        2 
Gierer 2004       *  *   *        3 
Gonzalez 2012  *                  1 
Gonzalez 2016  * *    *   *  *     4 
Guerci 2014  *   *   *   *        4 
Gulati 1998        * *   *        3 
Hermann 2007  *     * *   *        4 
Horstick 2002  *   *   *   *         4 
Hungerer  2006  *      *   *         3 
Kao  2010  *   *   *   *        4 
Kao 2011  *                   1 
Kerger  1997      *   *   *        3 
Komori 2005       *  *   *         3 
Kozar 2011       *  *   *         3 
Kubulus 2009  *    *  *   *         4 
Kumar 1997       *  *   *         3 
Maier  2004  * *   *     *        4 
Maier  2009  * *    *   *        4 
Mazzoni 1990 * *   * *  *   *        6 
Messmer  2012 * *   *   *   *        5 
Ni  2013  *    *      *         3 
Nolte 1997  *    *  *   *         4 
Ortiz 2014  *   *  * *   *        5 
Paes-da-Silva 2003  *    *  *   *         4 
Palmer 2011  *   *   *   *        4 
Pascual 2001  * *  *  *   *        5 
Pascual 2002  * *  *  *   *        5 
Paxian 2003       * * *   *         4 
Peruski 2014  * *    *   *        4 
Sakai 1999      *   *   *        3 
Sakai 2002        * *   *         3 
Scalia 1990       *  *   *         3 
Torres 2013  *    *  *   *         4 
Torres 2014  *   * *  *   *        5 
Torres 2015 (a)       *              1 
Torres 2015 (b)         *            1 
Vajda  2004  *    *  *   *         4 
Vazquez  2011  *   *   *   *        4 
Villela 2009  *   *  * *   *        5 
Villela 2011  *   *   *   *        4 
Vollmar 1994  * *  *  *   *        5 
Vollmar 1996  *         *         2 
von Dobschuetz  1999  *    *  *   *         4 
Wettstein 2003  *   *   *   *        4 
Wettstein  2004 (a)         *   *         2 
Wettstein 2004 (b)  *      *   *         2 
Wettstein 2006      * *  *   *        4 
Wu 2015 (a)  *    *  *   *         4 
Wu 2015 (b) * *    *  *   *         5 
Yada-Langui 2004  *    *      *         3 
Zakaria  2006  *    *  *   *         4 
Zhao  2009  *    *  *   *         4  
